M. Kobayashi

One-year outcomes of fixed treatment of intravitreal aflibercept for exudative age-related macular degeneration and the factor of visual prognosis

A. Tsujikawa, K. Hirooka, Saki Manabe, 2018, Medicine.

MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION

A. Tsujikawa, K. Hirooka, C. Shiragami, 2017, Retina.

Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival

K. Hirooka, Yukari Takasago, Yuki Nakano, 2018, Journal of the renin-angiotensin-aldosterone system : JRAAS.

The Relationship Between the Renin-Angiotensin-Aldosterone System and NMDA Receptor-Mediated Signal and the Prevention of Retinal Ganglion Cell Death.

A. Nishiyama, A. Tsujikawa, K. Hirooka, 2017, Investigative ophthalmology & visual science.

Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections

K. Suzuma, A. Tsujikawa, S. Ooto, 2017, Ophthalmologica.

Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.

K. Hirooka, C. Shiragami, Ayana Yamashita, 2018, American journal of ophthalmology.

CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS

A. Tsujikawa, C. Shiragami, Ayana Yamashita, 2017, Retina.

Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.

K. Hirooka, C. Shiragami, Ayana Yamashita, 2018, American journal of ophthalmology.